$BRZH
Breeze Holdings Acquisition Corp.

2023 Q1 Form 10-K Financial Statement

#000156459023004918 Filed on March 31, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $890.1K $712.5K $2.323M
YoY Change -9.64% 57.72% 34.88%
Operating Profit -$890.1K -$2.323M
YoY Change -9.64% 34.88%
Interest Expense $68.33K $0.00 $813.00
YoY Change 29.21% -100.0% -98.3%
% of Operating Profit
Other Income/Expense, Net $237.6K -$338.5K $6.113M
YoY Change -93.31% -119.38% -41.09%
Pretax Income -$652.6K -$1.051M $3.790M
YoY Change -125.41% -180.11% -56.45%
Income Tax $1.709K -$1.630K $2.089K
% Of Pretax Income 0.06%
Net Earnings -$654.3K -$1.049M $3.788M
YoY Change -125.48% -179.98% -56.48%
Net Earnings / Revenue
Basic Earnings Per Share -$0.14 $0.41
Diluted Earnings Per Share -$0.14 -$0.22 $0.41
COMMON SHARES
Basic Shares Outstanding 4.320M 4.830M 9.294M
Diluted Shares Outstanding 4.779M 9.294M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $37.57K $14.13K $14.13K
YoY Change 289.73% 161.67% 161.67%
Cash & Equivalents $37.57K $14.13K
Short-Term Investments
Other Short-Term Assets $169.5K $188.6K $188.6K
YoY Change 66.78% 51.88% 51.88%
Inventory
Prepaid Expenses $149.6K $160.5K
Receivables
Other Receivables
Total Short-Term Assets $207.0K $202.7K $202.7K
YoY Change 86.08% 56.46% 56.46%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $12.56M $17.73M $17.73M
YoY Change -89.45% -84.97% -84.97%
Other Assets
YoY Change
Total Long-Term Assets $12.56M $17.73M $17.73M
YoY Change -89.45% -84.97% -84.97%
TOTAL ASSETS
Total Short-Term Assets $207.0K $202.7K $202.7K
Total Long-Term Assets $12.56M $17.73M $17.73M
Total Assets $12.77M $17.93M $17.93M
YoY Change -89.29% -84.81% -84.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $338.2K $67.50K $67.50K
YoY Change -73.12% -88.72% -88.72%
Accrued Expenses $71.55K $0.00 $0.00
YoY Change -71.3% -100.0% -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $6.251M $5.481M
YoY Change 357.39%
Total Short-Term Liabilities $6.660M $5.551M $5.551M
YoY Change 61.91% 177.98% 177.98%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.016M $1.185M $1.185M
YoY Change -71.86% -83.33% -83.33%
Total Long-Term Liabilities $1.016M $1.185M $1.185M
YoY Change -71.86% -83.33% -83.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.660M $5.551M $5.551M
Total Long-Term Liabilities $1.016M $1.185M $1.185M
Total Liabilities $7.676M $6.735M $6.735M
YoY Change -0.6% -26.03% -26.03%
SHAREHOLDERS EQUITY
Retained Earnings -$7.413M -$6.532M
YoY Change -26.77%
Common Stock $315.00 $315.00
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$7.413M -$6.532M $11.20M
YoY Change
Total Liabilities & Shareholders Equity $12.77M $17.93M $17.93M
YoY Change -89.29% -84.81% -84.81%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$654.3K -$1.049M $3.788M
YoY Change -125.48% -179.98% -56.48%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$586.6K -$1.364M -$3.023M
YoY Change 111.94% 32458.0% 339.09%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $5.223M -$191.7K $100.4M
YoY Change -554.17% -83.33% -8828.36%
Cash From Investing Activities $5.223M -$191.7K $100.4M
YoY Change -554.17% -83.33% -8828.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $101.5M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.613M 1.570M -97.34M
YoY Change -422.36% 36.51% -8564.75%
NET CHANGE
Cash From Operating Activities -586.6K -1.364M -3.023M
Cash From Investing Activities 5.223M -191.7K 100.4M
Cash From Financing Activities -4.613M 1.570M -97.34M
Net Change In Cash 23.44K 14.05K 8.726K
YoY Change 452.96% -435.32% -101.27%
FREE CASH FLOW
Cash From Operating Activities -$586.6K -$1.364M -$3.023M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9294000
CY2022 dei Auditor Name
AuditorName
Marcum LLP
CY2022 dei Auditor Location
AuditorLocation
New York, NY
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
160503
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
123292
CY2022Q4 us-gaap Assets Current
AssetsCurrent
202705
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
17730969
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1198315
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-1722364
CY2021 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
47076
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-16948972
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-10378500
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10426340
CY2021 us-gaap Net Income Loss
NetIncomeLoss
8703976
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14631082
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.41
CY2022 brez Minimum Number Of Business Days To Redeem Public Shares
MinimumNumberOfBusinessDaysToRedeemPublicShares
P10D
CY2022 brez Warrants Redemption Covenant Threshold Trading Days
WarrantsRedemptionCovenantThresholdTradingDays
P20D
CY2022 brez Warrants Redemption Covenant Threshold Consecutive Trading Days
WarrantsRedemptionCovenantThresholdConsecutiveTradingDays
P30D
CY2022 brez Number Of Business Days Before Sending Notice Of Redemption Period
NumberOfBusinessDaysBeforeSendingNoticeOfRedemptionPeriod
P3D
CY2022 brez Number Of Trading Days Prior On Consummates Business Combination
NumberOfTradingDaysPriorOnConsummatesBusinessCombination
P20D
CY2022Q4 brez Business Combination Right Convertible Share Of Common Stock Conversion Ratio
BusinessCombinationRightConvertibleShareOfCommonStockConversionRatio
0.05
CY2022Q4 brez Business Combination Right Convertible Share Of Common Stock Conversion Ratio
BusinessCombinationRightConvertibleShareOfCommonStockConversionRatio
0.05
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
true
CY2022Q2 dei Entity Public Float
EntityPublicFloat
48957224
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4320484
CY2022 dei Auditor Firm
AuditorFirmId
688
CY2022Q4 us-gaap Cash
Cash
14129
CY2021Q4 us-gaap Cash
Cash
5403
CY2022Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
18073
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
865
CY2022Q4 brez Prepayment Franchise Taxes Current
PrepaymentFranchiseTaxesCurrent
10000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
129560
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
117931556
CY2022Q4 us-gaap Assets
Assets
17933674
CY2021Q4 us-gaap Assets
Assets
118061116
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
67500
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
598447
CY2021Q4 brez Franchise Tax Payable
FranchiseTaxPayable
200000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2089
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
5480941
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5550530
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1996762
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1184750
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
7108500
CY2022Q4 us-gaap Liabilities
Liabilities
6735280
CY2021Q4 us-gaap Liabilities
Liabilities
9105262
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1690196
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
11500000
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
17730156
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
117875000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3140000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3140000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3140000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3140000
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1690196
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
11500000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
315
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
315
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6532077
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8919461
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-6531762
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-8919146
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17933674
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
118061116
CY2022 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2323153
CY2022 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2323153
CY2021 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1722364
CY2021 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1722364
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-2323153
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-2323153
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-1722364
CY2022 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
813
CY2022 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
813
CY2021 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
764
CY2021 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
764
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
188903
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
188903
CY2021 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
47076
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-5923750
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-5923750
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-10378500
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6113466
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6113466
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10426340
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3790313
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3790313
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8703976
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8703976
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2089
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2089
CY2022 us-gaap Net Income Loss
NetIncomeLoss
3788224
CY2022 us-gaap Net Income Loss
NetIncomeLoss
3788224
CY2021 us-gaap Net Income Loss
NetIncomeLoss
8703976
CY2021 us-gaap Net Income Loss
NetIncomeLoss
8703976
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9294000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14631082
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14631082
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.41
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.41
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.59
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2021 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
1150000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
8703976
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-8919146
CY2022 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
1400840
CY2022 us-gaap Net Income Loss
NetIncomeLoss
3788224
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-6531762
CY2022 us-gaap Profit Loss
ProfitLoss
3788224
CY2021 us-gaap Profit Loss
ProfitLoss
8703976
CY2022 brez Interest And Unrealized Gain Loss On Investments
InterestAndUnrealizedGainLossOnInvestments
189716
CY2021 brez Interest And Unrealized Gain Loss On Investments
InterestAndUnrealizedGainLossOnInvestments
47076
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-5923750
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-10378500
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
401000
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
54419
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-36084
CY2022 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
95790
CY2021 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-111926
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-530947
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
531183
CY2022 brez Increase Decrease In Franchise Taxes Payable
IncreaseDecreaseInFranchiseTaxesPayable
-210000
CY2021 brez Increase Decrease In Franchise Taxes Payable
IncreaseDecreaseInFranchiseTaxesPayable
176844
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
2089
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3022729
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-688415
CY2022 us-gaap Payments To Acquire Trust Preferred Investments
PaymentsToAcquireTrustPreferredInvestments
1400840
CY2021 us-gaap Payments To Acquire Trust Preferred Investments
PaymentsToAcquireTrustPreferredInvestments
1150000
CY2022 brez Cash Withdrawn From Trust Account To Redeeming Shareholders
CashWithdrawnFromTrustAccountToRedeemingShareholders
101545684
CY2022 brez Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes
CashWithdrawnFromTrustAccountToPayFranchiseAndIncomeTaxes
231246
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
100376090
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1150000
CY2022 brez Proceeds From Short Term Working Capital Loan Related Party
ProceedsFromShortTermWorkingCapitalLoanRelatedParty
2800209
CY2022 brez Proceeds From Promissory Note Related Party
ProceedsFromPromissoryNoteRelatedParty
1400840
CY2021 brez Proceeds From Promissory Note Related Party
ProceedsFromPromissoryNoteRelatedParty
1150000
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
101545684
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-97344635
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1150000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8726
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-688415
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5403
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
693818
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14129
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5403
CY2021 brez Compensation Expense For Common Stock Purchased By Directors From Sponsor
CompensationExpenseForCommonStockPurchasedByDirectorsFromSponsor
401000
CY2021 us-gaap Stock Issued1
StockIssued1
74850
CY2022 brez Accretion Of Common Stocks Subject To Redemption Value
AccretionOfCommonStocksSubjectToRedemptionValue
1400840
CY2021 brez Accretion Of Common Stocks Subject To Redemption Value
AccretionOfCommonStocksSubjectToRedemptionValue
1150000
CY2020Q4 brez Sale Of Private Placement Warrants
SaleOfPrivatePlacementWarrants
5425000
CY2020Q4 brez Cost Of Per Private Placement Warrant
CostOfPerPrivatePlacementWarrant
1.00
CY2020Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
4099907
CY2020Q4 brez Underwriting Fees
UnderwritingFees
2300000
CY2020Q4 brez Other Offering Costs
OtherOfferingCosts
477557
CY2022Q4 us-gaap Cash
Cash
14129
CY2022Q4 brez Aggregate Fair Market Value Of Acquisition Threshold As Percentage Of Assets Held In Trust Account
AggregateFairMarketValueOfAcquisitionThresholdAsPercentageOfAssetsHeldInTrustAccount
0.80
CY2022 brez Minimum Voting Interest To Be Owned Or Acquired To Complete Business Combination
MinimumVotingInterestToBeOwnedOrAcquiredToCompleteBusinessCombination
0.50
CY2022Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.15
CY2022Q4 brez Business Combination Minimum Threshold Limit Of Net Intangible Assets Required
BusinessCombinationMinimumThresholdLimitOfNetIntangibleAssetsRequired
5000001
CY2022 brez Restriction On Public Share Redemption In Case Of Stockholder Approval Of Business Combination
RestrictionOnPublicShareRedemptionInCaseOfStockholderApprovalOfBusinessCombination
0.10
CY2022 brez Business Combination Incomplete Percentage Of Stock Redemption
BusinessCombinationIncompletePercentageOfStockRedemption
1
CY2022Q2 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.35
CY2022Q2 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
6732987
CY2022Q2 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
69700628
CY2022Q2 brez Cash Withdrawn From Trust Account
CashWithdrawnFromTrustAccount
109000
CY2022Q3 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.35
CY2022Q3 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
3076817
CY2022Q3 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
31845056
CY2022Q3 brez Cash Withdrawn From Trust Account
CashWithdrawnFromTrustAccount
122247
CY2022Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.035
CY2022Q3 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
59157
CY2022Q3 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
59157
CY2022 brez Business Combination Completion Date Of Acquisition
BusinessCombinationCompletionDateOfAcquisition
2023-09-26
CY2022Q4 brez Business Combination Incomplete Maximum Dissolution Expenses To Be Paid
BusinessCombinationIncompleteMaximumDissolutionExpensesToBePaid
100000
CY2022 brez Assets Remaining Available For Distribution Per Share Maximum
AssetsRemainingAvailableForDistributionPerShareMaximum
10.35
CY2022 brez Assets Remaining Available For Distribution Per Share Maximum
AssetsRemainingAvailableForDistributionPerShareMaximum
10.35
CY2022Q4 brez Business Combination Expected To Close
BusinessCombinationExpectedToClose
second or third quarter of 2023
CY2022Q4 us-gaap Cash
Cash
14129
CY2022Q4 brez Working Capital Deficit
WorkingCapitalDeficit
5345736
CY2020Q4 brez Proceeds From Sale Of Founder Shares
ProceedsFromSaleOfFounderShares
25000
CY2020Q4 brez Proceeds From Unsecured And Non Interest Bearing Promissory Notes
ProceedsFromUnsecuredAndNonInterestBearingPromissoryNotes
300000
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. </p>
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
11500000
CY2022 brez Offering Costs Incurred In Connection With Issuance Of Common Stock
OfferingCostsIncurredInConnectionWithIssuanceOfCommonStock
3704282
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2021Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2022 us-gaap Net Income Loss
NetIncomeLoss
3788224
CY2022 us-gaap Net Income Loss
NetIncomeLoss
3788224
CY2021 us-gaap Net Income Loss
NetIncomeLoss
8703976
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9294000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9294000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14631082
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.41
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.59
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Concentration of credit risk </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Deposit Insurance Corporate coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. </p>
CY2022 us-gaap Concentration Risk Credit Risk Financial Instrument Maximum Exposure
ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure
250000
CY2022 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:33.84%;"> <tr> <td style="width:33.84%;"/> </tr> <tr> <td valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Reclassification of Prior Year Presentation</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations. An adjustment has been made to the Balance Sheet as of December 31, 2022 and December 31, 2021. This change in classification does not affect previously reported amounts on the Balance Sheets presented or other statements herein.</p>
CY2022 brez Percentage Of Advisor Cash Fee On Gross Proceeds Of Initial Public Offering
PercentageOfAdvisorCashFeeOnGrossProceedsOfInitialPublicOffering
0.0275
CY2022 brez Cash Fee For Advisory Services Upon Consummation Of Business Combination
CashFeeForAdvisoryServicesUponConsummationOfBusinessCombination
3162500
CY2022Q4 brez Number Of Fractional Shares Issued Upon Exercise Of Public Warrant
NumberOfFractionalSharesIssuedUponExerciseOfPublicWarrant
0
CY2022 brez Warrants Exercisable Period After Completion Of Business Combination
WarrantsExercisablePeriodAfterCompletionOfBusinessCombination
P30D
CY2022 brez Warrants Exercisable Period From Closing Of Initial Public Offering
WarrantsExercisablePeriodFromClosingOfInitialPublicOffering
P12M
CY2022 brez Warrant Expiration Period After Completion Of Business Combination Or Earlier Upon Redemption Or Liquidation
WarrantExpirationPeriodAfterCompletionOfBusinessCombinationOrEarlierUponRedemptionOrLiquidation
P5Y
CY2022Q4 brez Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
0
CY2022Q4 brez Class Of Warrant Or Right Redemption Price
ClassOfWarrantOrRightRedemptionPrice
0.01
CY2022 brez Minimum Period Of Prior Written Notice Of Redemption Of Warrants
MinimumPeriodOfPriorWrittenNoticeOfRedemptionOfWarrants
P30D
CY2022Q4 brez Minimum Price Per Share Required For Redemption Of Warrants
MinimumPricePerShareRequiredForRedemptionOfWarrants
18.00
CY2022Q4 brez Maximum Effective Issue Price To Closing Of Business Combination
MaximumEffectiveIssuePriceToClosingOfBusinessCombination
9.20
CY2022Q4 brez Minimum Percentage Of Equity Proceeds From Issuances
MinimumPercentageOfEquityProceedsFromIssuances
0.60
CY2022Q4 brez Percentage Of Exercise Price Of Warrants Adjusted Equal To Higher Of Market Value And Issued Price
PercentageOfExercisePriceOfWarrantsAdjustedEqualToHigherOfMarketValueAndIssuedPrice
1.15
CY2022Q4 brez Minimum Price Per Share Required For Redemption Of Warrants
MinimumPricePerShareRequiredForRedemptionOfWarrants
18.00
CY2022 brez Percentage Of Redemption Triggered Price Of Warrants Adjusted Equal To Higher Of Market Value And Issued Price
PercentageOfRedemptionTriggeredPriceOfWarrantsAdjustedEqualToHigherOfMarketValueAndIssuedPrice
1.80
CY2022 brez Warrants Will Not Be Transferable Assignable Or Saleable Number Of Period After Completion Of Business Combination
WarrantsWillNotBeTransferableAssignableOrSaleableNumberOfPeriodAfterCompletionOfBusinessCombination
P30D
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
5425000
CY2022Q4 brez Warrant Price Per Share
WarrantPricePerShare
1.00
CY2022Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
5425000
CY2022Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1
CY2022Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-5923750
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-10378500
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022 us-gaap Common Stock Voting Rights
CommonStockVotingRights
Holders of common stock are entitled to one vote for each share.
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3140000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3140000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3140000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3140000
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1690196
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
11500000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
23712
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
36963
CY2022Q4 brez Deferred Tax Assets Capitalized Start Up Costs
DeferredTaxAssetsCapitalizedStartUpCosts
598616
CY2021Q4 brez Deferred Tax Assets Capitalized Start Up Costs
DeferredTaxAssetsCapitalizedStartUpCosts
302805
CY2021Q4 brez Deferred Tax Liabilities Unrealized Gains On Investments
DeferredTaxLiabilitiesUnrealizedGainsOnInvestments
2107
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
622328
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
337661
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
622328
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
337661
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
2089
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-284667
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-267403
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
284667
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
267403
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2089
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
112915
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
176014
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
622328
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
337661
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2022 brez Effective Income Tax Rate Reconciliation Change In Fair Market Value Of Warrant Liabilities
EffectiveIncomeTaxRateReconciliationChangeInFairMarketValueOfWarrantLiabilities
-0.3282
CY2021 brez Effective Income Tax Rate Reconciliation Change In Fair Market Value Of Warrant Liabilities
EffectiveIncomeTaxRateReconciliationChangeInFairMarketValueOfWarrantLiabilities
-0.2500
CY2022 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
0.0191
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.0246
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.0100
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.0751
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.0300
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0006
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
7108500
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
5923750
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1184750
CY2022Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.035
CY2022Q3 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
59157

Files In Submission

Name View Source Status
0001564590-23-004918-index-headers.html Edgar Link pending
0001564590-23-004918-index.html Edgar Link pending
0001564590-23-004918.txt Edgar Link pending
brez-20221231_cal.xml Edgar Link unprocessable
brez-20221231_def.xml Edgar Link unprocessable
0001564590-23-004918-xbrl.zip Edgar Link pending
brez-10k_20221231.htm Edgar Link pending
brez-20221231.xsd Edgar Link pending
brez-ex311_7.htm Edgar Link pending
brez-ex321_6.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
brez-20221231_lab.xml Edgar Link unprocessable
brez-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
brez-10k_20221231_htm.xml Edgar Link completed
Show.js Edgar Link pending